Evidence map›Paper›PMID 28744357›Full record

ArticleToxicological research2017

Evaluation of the Effect of Pentoxifylline on Cisplatin-Induced Testicular Toxicity in Rats.

Ali Reza Fallahzadeh, Zohreh Rezaei, Hamid Reza Rahimi, Mehrazd Jafari Barmak, Hossein Sadeghi, Sadrollah Mehrabi, Seyed Mohammadreza Rabani, Iraj Ragerdi Kashani, Vahid Barati, Reza Mahmoudi

Open access · hybridAbstract read
In one paragraph

Article in Toxicological research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Roasted cashew (Heliyon · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ali Reza FallahzadehCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Zohreh RezaeiStudent Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.
Hamid Reza RahimiPharmaceutics Research Center, Institute of Neuropharmacology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
Mehrazd Jafari BarmakCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Hossein SadeghiCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Sadrollah MehrabiCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Seyed Mohammadreza RabaniCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Iraj Ragerdi KashaniDepartment of Anatomical Sciences, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Vahid BaratiStudent Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.
Reza MahmoudiCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Yasuj University of Medical Sciences · IRKerman University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy is associated with male infertility. Cisplatin (cis-diamminedichloro-platinum (II) (CDDP) as a chemotherapy medication used to treat a number of cancers has been reported to most likely induce testicular toxicity. Administration of antioxidants, such as pentoxifylline (PTX) may reduce some Adverse Drug Reactions (ADRs) of CDDP. Therefore, this study investigated the potentially protective effects of PTX on CDDP-induced testicular toxicity in adult male rats. For this purpose, 42 male rats were randomly divided into 7 groups. The rats were orally pretreated with PTX at the 3 doses of 75, 150, and 300 mg/kg once a day for 14 successive days. On the 14

Indexed as

AntioxidantChemotherapyHistopathological featureSperm motilityTesticular toxicity

Identifiers

PMID28744357
PMCPMC5523557
OpenAlexW2734747373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.